Agilent to acquire Biocare Medical for $950M, supercharging cancer diagnostics portfolio
The acquisition of Biocare enhances Agilent’s pathology portfolio and reflects our strategy to drive long-term growth
The acquisition of Biocare enhances Agilent’s pathology portfolio and reflects our strategy to drive long-term growth
The inspection concluded with zero observations, confirming the facility's compliance with current Good Manufacturing Practices
UK headquartered digital health scale-up strengthens global tech and innovation footprint in the country
India plays a critical role in Bristol Myers Squibb’s global strategy
Granules Consumer Health serves as Granules’ front-end division for OTC products in the US
Acquisition strengthens EY’s Veeva Centers of Excellence, expanding clinical, regulatory, and commercial services for global pharma and biotech companies
Maria Soler Nunez appointed as Chief Quality Officer
The first pillar is advanced manufacturing, focused on upgrading existing CDMO
Subscribe To Our Newsletter & Stay Updated